Virtual Incision

Virtual Incision, founded in 2006 and based in Lincoln, Nebraska, is pioneering the development of the world's first Miniaturized Robotic-Assisted Surgery (RAS) System, known as MIRA. With a focus on simplifying robotic-assisted surgery, Virtual Incision aims to broaden access to its benefits for both patients and surgeons. The company holds an impressive 200 patents and patent applications and is currently advancing MIRA through FDA clinical trials under an Investigational Device Exemption (IDE), with a primary focus on bowel resection. In September 2023, the company secured a significant $30.00M Series C investment from a notable group of investors, including Arboretum Ventures, Baird Capital, Bluestem Capital, Cultivate(MD), Endeavour Vision, PrairieGold Venture Partners, Invictum Capital, and InVivium Capital. Virtual Incision's innovative approach to robotic surgery, combined with the substantial support from prominent investors, positions the company for significant growth and potential impact within the Health Care and Robotics industries. Follow Virtual Incision for ongoing updates on its groundbreaking MIRA platform. [Source: Virtual Incision]